Shows

NEWYou can now listen to Fox News articles! Sitting next to a window may help people with type 2 diabetes control their insulin levels, according to new research. The study, …

An international group of scientists led by Professor Marc-Emmanuel Dumas at Imperial College London & CNRS, along with Prof. Patrice Cani (Imperial & University of Louvain, UCLouvain), Dr. Dominique Gauguier …

Metformin Shows No Benefit for lowering Insulin Resistance in Type 1 Diabetes: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of …

Amycretin (Novo Nordisk), a unimolecular agonist of glucagon-like peptide 1 (GLP-1) and amylin receptors, induced significant weight loss and hemoglobin A1c (HbA1c) reductions in patients with type 2 diabetes in …

A research team at Mass General Brigham has released new evidence directly comparing how well tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) protect the heart. According to the analysis, both …

A breakthrough weight loss pill from the maker of Mounjaro helped patients shed weight and slash high blood sugar, promising data has shown. A late stage trial showed users could lose almost 10 …

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings …

The number of New Yorkers at risk of developing Type 2 diabetes more than doubled between 2011 and 2023, according to recent data released by the state Department of Health. …

Finerenone (Kerendia) significantly reduced urine albumin-to-creatinine ratio (UACR) by 25% from baseline to 6 months compared with the placebo for patients with type 1 diabetes (T1D) and chronic kidney disease …

People with type 1 diabetes achieved significantly better long-term blood glucose when their levels were monitored by healthcare professionals in real time, via a sensor under the skin, and they …